Cefuroxime Injection, Powder, For Solution
Product Images NDC 0143-9567

8 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cefuroxime (NDC 0143-9567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cefuroxime Chemical Structure (Cefuroxime For Injection Novaplus 1)

Cefuroxime Chemical Structure (Cefuroxime For Injection Novaplus 1)
Chemical structure of Cefuroxime, showing its molecular framework with labeled functional groups and bonds characteristic of this antibiotic molecule.*
FDA Label Image

Ndc 0143-9568-01 Rx Only Cefuroxime For Injection, Usp For Iv Or Im Use 750 mg*/vial Protect From Light *each Vial Contains Sterile Cefuroxime Sodium Equiva- Lent To Cefuroxime 750 mg. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Im Suspension: Add 3 mL Of Sterile Water For Injection. Shake Gently To Dispense And Withdraw Completely The Resulting Suspension For Injection. For Iv Solution: Add 8.3 mL Of Sterile Water For Injec- Tion. Shake Until Dissolved And Withdraw Completely The Resulting Solution For Injection. After Constitution, The Suspension And Solution Maintain Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf). (Cefuroxime For Injection Novaplus 2)

Ndc 0143-9568-01 Rx Only Cefuroxime For Injection, Usp For Iv Or Im Use 750 mg*/vial Protect From Light *each Vial Contains Sterile Cefuroxime Sodium Equiva- Lent To Cefuroxime 750 mg. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Im Suspension: Add 3 mL Of Sterile Water For Injection. Shake Gently To Dispense And Withdraw Completely The Resulting Suspension For Injection. For Iv Solution: Add 8.3 mL Of Sterile Water For Injec- Tion. Shake Until Dissolved And Withdraw Completely The Resulting Solution For Injection. After Constitution, The Suspension And Solution Maintain Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf). (Cefuroxime For Injection Novaplus 2)
Label for Cefuroxime injection, powder for solution, 750 mg per vial, by Hikma Pharmaceuticals USA Inc. The label specifies use for intravenous or intramuscular injection, includes dosage preparation instructions, storage conditions, and manufacturer and distributor information. The brand NOVAPLUS is also mentioned.*
FDA Label Image

Ndc 0143-9568-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Or Intramuscular Use 750 mg*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials (Cefuroxime For Injection Novaplus 3)

Ndc 0143-9568-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Or Intramuscular Use 750 mg*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials (Cefuroxime For Injection Novaplus 3)
Cefuroxime 750 mg/vial injection powder for solution carton label. The label states the product is for intravenous or intramuscular use, supplied in a carton of 25 vials. It is labeled as USP grade and carries instructions to protect from light and retain the carton until time of use. Manufactured by Hikma Farmacêutica (Portugal) and distributed by West-Ward (NJ, USA). The brand name NOVAPLUS is also shown on the carton.*
FDA Label Image

Ndc 0143-9568-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Or Intramuscular Use 750 mg*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 750 mg. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Im Suspension: Add 3 mL Of Sterile Water For Injection. Shake Gently To Disperse And Withdraw Completely The Resulting Suspension For Injection. For Iv Solution: Add 8.3 mL Of Sterile Water For Injection. Shake Until Dissolved And Withdraw Completely The Resulting Solution For Injection. After Constitution, The Suspension And Solution Maintain Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store Upright. (Cefuroxime For Injection Novaplus 4)

Ndc 0143-9568-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Or Intramuscular Use 750 mg*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 750 mg. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Im Suspension: Add 3 mL Of Sterile Water For Injection. Shake Gently To Disperse And Withdraw Completely The Resulting Suspension For Injection. For Iv Solution: Add 8.3 mL Of Sterile Water For Injection. Shake Until Dissolved And Withdraw Completely The Resulting Solution For Injection. After Constitution, The Suspension And Solution Maintain Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store Upright. (Cefuroxime For Injection Novaplus 4)
Cefuroxime 750 mg/vial injection powder for solution by Hikma Pharmaceuticals USA Inc. This label indicates intravenous or intramuscular use, packaged in a carton of 25 vials. Instructions include preparation of suspension or solution with sterile water and storage conditions. The vial contains cefuroxime sodium equivalent to 750 mg cefuroxime.*
FDA Label Image

Ndc 0143-9567-01 Rx Only Cefuroxime For Injection, Usp For Iv Use Only 1.5 G*/vial Protect From Light *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 1.5 G. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity.usual Dosage: See Package Insert. For Iv Solution: Add 16 mL Of Sterile Water For Injection. Shake Well To Dissolve. Withdraw Completely The Resulting Solution For Injection. After Constitution, The Solution Maintains Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf). Date And Time Prepared: _______/_______ (Cefuroxime For Injection Novaplus 5)

Ndc 0143-9567-01 Rx Only Cefuroxime For Injection, Usp For Iv Use Only 1.5 G*/vial Protect From Light *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 1.5 G. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity.usual Dosage: See Package Insert. For Iv Solution: Add 16 mL Of Sterile Water For Injection. Shake Well To Dissolve. Withdraw Completely The Resulting Solution For Injection. After Constitution, The Solution Maintains Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf). Date And Time Prepared: _______/_______ (Cefuroxime For Injection Novaplus 5)
Label for Cefuroxime Injection, USP 1.5 g per vial by Hikma Pharmaceuticals USA Inc. The label indicates it is for intravenous use only, includes preparation instructions to add sterile water, storage conditions, and cautions to protect from light. It also shows distributor information for West-Ward, Eatontown, NJ.*
FDA Label Image

Ndc 0143-9567-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Use Only 1.5 G*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials (Cefuroxime For Injection Novaplus 6)

Ndc 0143-9567-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Use Only 1.5 G*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials (Cefuroxime For Injection Novaplus 6)
Cefuroxime for Injection, USP, 1.5 g per vial, powder for solution. The label indicates intramuscular and intravenous use and advises protecting from light and retaining the vial in carton until time of use. The product is supplied by Hikma Pharmaceuticals USA Inc. in a carton containing 25 vials. The label includes branding for NOVAPLUS and manufacturing information from Hikma Farmacêutica (Portugal).*
FDA Label Image

Ndc 0143-9567-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Use Only 1.5 G*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 1.5 G. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Iv Solution: Add 16 mL Of Sterile Water For Injection. Shake Well To Dissolve. Withdraw Completely The Resulting Solution For Injection. After Constitution, The Solution Maintains Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store Upright. (Cefuroxime For Injection Novaplus 7)

Ndc 0143-9567-25 Rx Only Cefuroxime For Injection, Usp For Intravenous Use Only 1.5 G*/vial Protect From Light Retain In Carton Until Time Of Use Carton Of 25 Vials *each Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 1.5 G. The Sodium Content Is Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. For Iv Solution: Add 16 mL Of Sterile Water For Injection. Shake Well To Dissolve. Withdraw Completely The Resulting Solution For Injection. After Constitution, The Solution Maintains Potency For 24 Hours At Room Temperature Or 48 Hours Under Refrigeration (5ºc Or 41ºf). Color Changes In Solution Do Not Affect Potency. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. Store Upright. (Cefuroxime For Injection Novaplus 7)
Cefuroxime for Injection USP 1.5 g per vial, injection powder for solution by Hikma Pharmaceuticals USA Inc. The label indicates it is for intravenous use only, comes in a carton of 25 vials, and includes storage instructions to protect from light and retain in the carton until use. The product is branded as NOVAPLUS®.*
FDA Label Image

Cefuroxime For Injection Novaplus 8

Cefuroxime For Injection Novaplus 8
A label panel includes a QR code and text fields showing GTIN, serial number, expiration date, and lot number. The product is Cefuroxime injection, powder for solution, but only the label information fields are visible, with no branding or strength details shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.